**Five research priorities for 2027–2031 — research-council forecast**
Evidence cutoff: 6 September 2026. Final, independently reviewed within the bounded scope.

**Our base-case selection is: (1) AI and AI-enabled discovery, (2) energy storage, grids and energy materials, (3) biotechnology and precision health, (4) advanced semiconductors and efficient computing, and (5) robotics and autonomous physical systems.** The first four have broader support across the inspected evidence; fifth place is the most sensitive to how “main focus” is defined. Quantum is a serious alternative; the evidence cannot establish an objective fifth-place winner.

This is a forecast of major expanding research priorities in global applied science and technology, not a measured ranking of all academic disciplines. It combines research scale, momentum, industry requirements, funding and unresolved technical problems. The evidence does not support exact percentages of researchers, a reliable five-year CAGR, or precise ordering between close candidates. All future-facing conclusions have a **low confidence ceiling under the conservative evidence rubric**, because historical observations only support them inferentially. That limitation is separate from confidence in the underlying reported facts.

| Tentative order | Research area | Expected 2027–2031 direction — analyst forecast | Research problems most likely to attract attention |
|---|---|---|---|
| 1 | AI methods and AI-enabled scientific discovery | Broad expansion across disciplines | Reliability, evaluation, efficient learning, scientific reasoning, reproducible workflows and experimental validation |
| 2 | Energy storage, grids and enabling materials | Strong but uneven expansion | Affordable durable storage, battery safety/recycling, grid integration, power electronics and materials performance |
| 3 | Biotechnology and precision health | Large continuing base; mixed growth signals | Computational biology, biological engineering, biomarkers, delivery/manufacturing and clinical validation |
| 4 | Advanced semiconductors and efficient computing | Expansion around physical constraints | Advanced packaging, memory/interconnect, photonics, power delivery, cooling, yield and reliability |
| 5 | Robotics and autonomous physical systems | Expansion is plausible; weakest top-five placement | Robust perception, manipulation, safe control, integration and dependable operation outside demonstrations |

The listed subtopics are research hypotheses grounded in the identified problems, not separately validated rankings.

**1. AI is both a research field and a method spreading through other fields.**

The strongest signal is the convergence of scientific adoption, inventive activity and expected industrial use. WIPO counted **54,358 published GenAI patent families in 2014–2023**, with more than 14,000 in 2023 and roughly 45% average annual growth since 2017. These historical family counts cannot be projected mechanically through 2031. [WIPO GenAI landscape](https://www.wipo.int/web-publications/patent-landscape-report-generative-artificial-intelligence-genai/en/2-global-patenting-and-research-in-genai.html)

A study of 41.3 million papers reports accelerating AI adoption in six natural-science fields. Its classifier and observational design have limitations; the authors explicitly cannot fully identify causal effects on scientific impact. Meanwhile, 86% of employers in the WEF survey expect AI/information processing to transform their business by 2030. Scientific adoption and employer expectations are complementary signals, not two measures of research output. [Original author manuscript](https://arxiv.org/html/2412.07727v4), [WEF survey](https://www.weforum.org/publications/the-future-of-jobs-report-2025/digest/)

My forecast is that attention will increasingly move toward **making AI dependable enough to use in consequential work and scientific experiments**. More papers or benchmarks alone will not establish better science. Evidence of weak reproducibility, limited experimental benefit, or sustained funding retrenchment would weaken this forecast.

**2. Energy research has a persistent problem: delivering useful electricity reliably and affordably.**

IEA estimated power-sector battery investment at **$66 billion in 2025**, while annual grid investment was about $400 billion against roughly $1 trillion for generation. This signals deployment pressure and uneven infrastructure development. It is not an R&D expenditure estimate. DOE’s Basic Energy Sciences programme explicitly supports the materials and chemical science underlying generation, conversion, transmission and storage. [IEA investment outlook](https://www.iea.org/reports/world-energy-investment-2025/executive-summary), [DOE research scope](https://www.energy.gov/science/bes/basic-energy-sciences)

Patent evidence also points toward electrification: EPO battery applications rose **14.6% in 2025**. This is a European-office measure, covering applicants worldwide, rather than a worldwide family-growth rate. [EPO dashboard release](https://www.epo.org/en/news-events/press-centre/press-release/2026/1362106)

The forecast favors storage, integration, power systems and materials. It does not assume hydrogen, fusion, carbon capture or any particular battery chemistry becomes a commercial winner by 2031. A substantial part of the electricity bottleneck is permitting, finance, supply chains and construction, so an engineering research breakthrough alone cannot remove it.

**3. Biomedicine belongs because of its scale and scientific opportunity; its growth signals are mixed.**

NSF reports health sciences accounted for **22% of global publications in 2024**, with biological/biomedical sciences reported separately at 12%. It also reports **$136 billion of U.S. business biotechnology R&D in 2023**. These show a substantial base, not proof that a narrow modality is accelerating. NIH’s 2025–2030 data-science plan prioritizes human-derived data, AI/software methods and federated biomedical infrastructure. [NSF research indicators](https://ncses.nsf.gov/pubs/nsbsep20261/discovery-r-d-activity-and-research-publications-2), [NIH strategic plan](https://datascience.nih.gov/nih-strategic-plan-data-science)

The contrary signal matters: **EPO biotechnology applications declined 3.3% and pharmaceuticals 6.3% in 2025**, while medical technology increased 1.3%. This weakens a uniform-growth narrative. It does not establish that global biomedical research is declining. OECD also identifies long development timelines, expensive testing, risk and finance as central biotechnology constraints. [EPO data](https://www.epo.org/en/news-events/press-centre/press-release/2026/1362106), [OECD biotechnology analysis](https://www.oecd.org/en/publications/boosting-biotechnology-innovation-through-agile-regulation-and-finance-instruments_7cd12966-en/full-report.html)

The research opportunity is to turn biological understanding into **reproducible, manufacturable and clinically useful interventions**. Computational biology and engineered platforms are plausible concentrations; this run cannot rank gene editing, cancer, metabolic disease or other therapeutic subfields. Sustained declines in research funding, trial activity or successful translation would lower its placement.

**4. Computing hardware deserves a separate place because physical limits create distinct research problems.**

IEA reports data centres consumed **415 TWh in 2024** and projects about **945 TWh in 2030 in its Base Case**. NIST reports **$300 million in finalized advanced-substrate/materials research awards** and explicitly identifies assembly, power, heat, testing and reliability problems in advanced packaging. EPO semiconductor applications rose 7.6% in 2025. [IEA Energy and AI](https://www.iea.org/reports/energy-and-ai/executive-summary), [NIST packaging programme](https://www.nist.gov/chips/research-development-programs/national-advanced-packaging-manufacturing-program), [EPO](https://www.epo.org/en/news-events/press-centre/press-release/2026/1362106)

These requirements support research into memory movement, interconnect, packaging, thermal management and hardware/software co-design. Company spending reinforces the buyer signal—Alphabet reported $52.5 billion of 2024 capex—but capex is not research spending, and one company does not represent the world. [Alphabet 2024 filing](https://www.sec.gov/Archives/edgar/data/1652044/000165204425000014/goog-20241231.htm)

AI monetization disappointing, capital spending contracting or efficiency gains relieving capacity pressure could slow expansion. General AI methods are assigned to area 1; semiconductor devices and physical computing systems are assigned here.

**5. Robotics has an installed industrial base, but its research-growth case needs the most qualification.**

IFR reports **4.66 million industrial robots operating in 2024**, up 9%, with approximately 11% average annual stock growth since 2019. Annual installations were uneven across regions. WEF’s employer survey places robotics/automation among widely anticipated business changes, while WIPO’s transportation analysis identifies momentum in automation and related systems. [IFR executive summary](https://ifr.org/img/worldrobotics/Executive_Summary_WR_2025_Industrial_Robots.pdf), [WEF](https://www.weforum.org/publications/the-future-of-jobs-report-2025/digest/), [WIPO transportation landscape](https://www.wipo.int/web-publications/wipo-technology-trends-future-of-transportation/en/3-ip-and-technology-trends-shaping-the-future-of-transportation.html)

The defensible research hypothesis is **robots that work reliably across changing objects, tasks and environments**, including perception, manipulation, control and integration. It is not a prediction of mass humanoid adoption. Operational robot stock is not researcher headcount, and transport patents do not cover all robotics. Missing comparable publication and research-funding trends make this the easiest area to replace.

**The intersections provide a non-ranked agenda for further investigation.**

| Intersection | Concrete research question to investigate |
|---|---|
| AI × biology | Can a model generate useful hypotheses that survive independent experimental and clinical validation? |
| AI × energy materials | Can computation plus automated experiments identify materials that retain performance under realistic operating conditions? |
| Computing hardware × energy | Can useful computation grow faster than its power, cooling and material requirements? |
| Robotics × experimental science | Can physical systems collect new, reliable data and execute experiments beyond tightly scripted conditions? |

These are proposed directions, not findings that they outperform every alternative. They follow from NIH’s data/AI agenda, DOE’s materials research scope, NIST’s hardware constraints and the observed spread of AI across natural-science research. The experimental questions themselves are proposed inferences. [NIH](https://datascience.nih.gov/nih-strategic-plan-data-science), [DOE](https://www.energy.gov/science/bes/basic-energy-sciences), [NIST](https://www.nist.gov/chips/research-development-programs/national-advanced-packaging-manufacturing-program), [Original study](https://arxiv.org/html/2412.07727v4)

**Quantum challenges the fifth-place selection; other important alternatives remain open.**

Quantum could replace robotics if the priority is frontier research growth rather than a combination of scale and deployed industrial requirements. OECD/EPO report about 20% annual quantum international-patent-family growth since 2014, alongside uneven private investment after a 2021 peak. **Slow commercialization does not mean weak research prospects**: unresolved technical barriers can sustain intensive research. The present evidence cannot settle fifth place objectively. [OECD/EPO quantum study summary](https://www.oecd.org/en/about/news/press-releases/2025/12/mapping-the-global-quantum-ecosystem.html)

Cybersecurity has strong demand signals, including reported cybercrime losses and expected skills demand, but this run lacks comparable global security-research growth measures. Climate adaptation, water and food security have compelling needs and public programme support, yet need does not guarantee funding: UNEP reports international public adaptation finance to developing countries fell from $28 billion in 2022 to $26 billion in 2023. [FBI IC3](https://www.ic3.gov/AnnualReport/Reports/2024_IC3Report.pdf), [UNEP](https://www.unep.org/resources/adaptation-gap-report-2025), [EU priorities](https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe/strategic-plan_en?prefLang=hu)

Digital communications/6G, agricultural technology, space, broader environmental science and social-science research deserve further comparison. They were not investigated at equal depth; omission is not evidence of lower importance.

**How the council tested the forecast**

Three agents independently investigated scientific activity, patents, and industry/business demand. They then cross-reviewed original sources. The coordinator inspected scientific sources and synthesized the field boundaries; separate agents reviewed the resulting claims and report. No agent vote determined the answer.

Source credibility and forecast confidence are distinct. Institutional patent and funding records are generally strong for their defined counts and programme statements. IEA estimates are model-based. WEF expectations, IFR industry statistics and official study summaries carry sampling, method or incentive limits. The AI-science paper is an original observational analysis, not causal proof. Per-source rationales are in the evidence packet.

The comparison uses five dimensions—scientific activity, industrial need, inventive activity, funding and unresolved research problems—without adding incompatible units into a numerical score. Areas share drivers and techniques; we allocate research by its main technical problem and never sum their market sizes, patent counts or funding.

Review changed the result: narrow precision-therapy claims were broadened; biotech patent declines were retained; quantum’s ranking stayed unresolved; a digital-agriculture search description was excluded as unread evidence. A reviewer initially misclassified September 2025 sources as beyond the September 2026 cutoff; that error was corrected in a retained second review. The original speculative lane rankings remain WIP records, not final empirical conclusions.

Coverage is strongest for public international statistics and U.S./EU research programmes. Patent and deployment datasets include Asia, but direct Chinese, Indian and other national funding plans were not systematically reviewed. Subscription bibliometrics, paid patent analytics and private venture datasets were not used. One Nature publisher page failed; its versioned author manuscript was read instead. The digital-agriculture PDF remained an access gap. No account creation or paid access was needed.

The next decisive improvement would be comparable three-to-five-year publication, active-researcher, grant and patent-family time series under a fixed field taxonomy—especially for robotics versus quantum, and subfields within biotechnology. The current report stops at a bounded, independently challenged forecast with these gaps explicit; it is not an exhaustive worldwide research census.

**Research status: complete within the bounded qualitative scope.** All 15 final claims received independent review. Eight bounded observation claims are reported at moderate confidence; five field forecasts and the two alternative/intersection claims are low-confidence inferences. Biotechnology retains contrary evidence. These are ordinal judgments, not probabilities.

The evidence gate ran successfully and the bundled 18 tests passed. It validates evidence-packet structure, source-ID references and conservative confidence ceilings; it does not verify source truth, report URLs or forecast accuracy. The report’s semantic review passed after the recorded wording corrections. Native todo tracking was unavailable.

Files: [evidence ledger](/Users/yonatangeffen/dev/Futuristic/research/2026-09-06-five-year-outlook/evidence-ledger.md), [frozen evidence packet](/Users/yonatangeffen/dev/Futuristic/research/2026-09-06-five-year-outlook/evidence-packet-002.json), [gate receipt](/Users/yonatangeffen/dev/Futuristic/research/2026-09-06-five-year-outlook/gate-receipt-002.json), [research plan](/Users/yonatangeffen/dev/Futuristic/research/2026-09-06-five-year-outlook/research-plan.json), [coverage and access status](/Users/yonatangeffen/dev/Futuristic/research/2026-09-06-five-year-outlook/research-status.json), [report review](/Users/yonatangeffen/dev/Futuristic/research/2026-09-06-five-year-outlook/report-review.md).